Healthequity Inc
NASDAQ:HQY

Watchlist Manager
Healthequity Inc Logo
Healthequity Inc
NASDAQ:HQY
Watchlist
Price: 92.8 USD -1.04%
Market Cap: 7.9B USD
Section:
 

Relative Value

The Relative Value of one HQY stock under the Base Case scenario is 123.17 USD. Compared to the current market price of 92.8 USD, Healthequity Inc is Undervalued by 25%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HQY Relative Value
Base Case
123.17 USD
Undervaluation 25%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

6.2
P/S
P/S
Price to Sales
6.2
vs History
65
vs Industry
20
Median 3Y
6.3
Median 5Y
6.5
Industry
2.3
Forward
6
More Details
41.4
P/E
P/E
Price to Earnings
41.4
vs History
65
vs Industry
5
Median 3Y
71.6
Median 5Y
71.6
Industry
22.4
Forward
23.8
More Details
19.1
P/OCF
P/OCF
Price to OCF
19.1
vs History
98
vs Industry
16
Median 3Y
26.4
Median 5Y
28.8
Industry
14.4
More Details
36.1
P/FCFE
P/FCFE
Price to FCFE
36.1
vs History
36
vs Industry
9
Median 3Y
37.2
Median 5Y
-36.5
Industry
21.7
More Details
3.7
P/B
P/B
Price to Book Value
3.7
vs History
20
vs Industry
22
Median 3Y
3.4
Median 5Y
3.2
Industry
2.2
More Details
6.7
EV/S
EV/S
Enterprise Value to Sales
6.7
vs History
68
vs Industry
17
Median 3Y
7
Median 5Y
7.3
Industry
2.5
Forward
6.6
More Details
9.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.9
vs History
92
vs Industry
18
Median 3Y
11.4
Median 5Y
12
Industry
5.1
More Details
19.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.1
vs History
98
vs Industry
14
Median 3Y
24.9
Median 5Y
27.1
Industry
12
Forward
15.4
More Details
29.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
29.1
vs History
96
vs Industry
10
Median 3Y
53.6
Median 5Y
73.1
Industry
16.9
Forward
25.3
More Details
20.8
EV/OCF
EV/OCF
Enterprise Value to OCF
20.8
vs History
98
vs Industry
15
Median 3Y
28.8
Median 5Y
30.7
Industry
14.5
More Details
23.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
23.8
vs History
68
vs Industry
12
Median 3Y
35.5
Median 5Y
38.1
Industry
18.6
More Details
2.8
EV/IC
EV/IC
Enterprise Value to IC
2.8
vs History
14
vs Industry
29
Median 3Y
2.6
Median 5Y
2.5
Industry
1.8
More Details

Multiples Across Competitors

HQY Competitors Multiples
Healthequity Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Healthequity Inc
NASDAQ:HQY
7.9B USD 6.2 41.4 19.1 29.1
US
UnitedHealth Group Inc
NYSE:UNH
296.2B USD 0.7 16.8 11.1 12.9
US
Anthem Inc
LSE:0HG8
89B USD 0.5 16 11.2 13.2
US
Elevance Health Inc
NYSE:ELV
76.2B USD 0.4 13.8 9.9 11.7
US
Humana Inc
NYSE:HUM
30.8B USD 0.2 23.9 8.9 11.2
US
Centene Corp
NYSE:CNC
19.5B USD 0.1 -3.7 7.6 16.1
US
Molina Healthcare Inc
NYSE:MOH
8.3B USD 0.2 9.4 2.5 2.8
US
Magellan Health Inc
F:MAH1
2.2B EUR 0.5 8.6 13.1 38.9
US
Progyny Inc
NASDAQ:PGNY
2.3B USD 1.8 40 21.9 23
US
Clover Health Investments Corp
NASDAQ:CLOV
1.3B USD 0.7 -22.4 -20.1 -19.5
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
6.9B BRL 0.4 -14.4 3.2 5.7
P/E Multiple
Earnings Growth PEG
US
Healthequity Inc
NASDAQ:HQY
Average P/E: 21.2
41.4
67%
0.6
US
UnitedHealth Group Inc
NYSE:UNH
16.8
10%
1.7
US
A
Anthem Inc
LSE:0HG8
16
6%
2.7
US
Elevance Health Inc
NYSE:ELV
13.8
6%
2.3
US
Humana Inc
NYSE:HUM
23.9
25%
1
US
Centene Corp
NYSE:CNC
Negative Multiple: -3.7
-15%
N/A
US
Molina Healthcare Inc
NYSE:MOH
9.4
-10%
N/A
US
M
Magellan Health Inc
F:MAH1
8.6
N/A N/A
US
Progyny Inc
NASDAQ:PGNY
40
27%
1.5
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -22.4 N/A N/A
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Negative Multiple: -14.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Healthequity Inc
NASDAQ:HQY
Average EV/EBITDA: 10.8
19.1
26%
0.7
US
UnitedHealth Group Inc
NYSE:UNH
11.1
-3%
N/A
US
A
Anthem Inc
LSE:0HG8
11.2
1%
11.2
US
Elevance Health Inc
NYSE:ELV
9.9
1%
9.9
US
Humana Inc
NYSE:HUM
8.9
4%
2.2
US
Centene Corp
NYSE:CNC
7.6
-18%
N/A
US
Molina Healthcare Inc
NYSE:MOH
2.5
-10%
N/A
US
M
Magellan Health Inc
F:MAH1
13.1
N/A N/A
US
Progyny Inc
NASDAQ:PGNY
21.9
58%
0.4
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -20.1 N/A N/A
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
3.2
8%
0.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Healthequity Inc
NASDAQ:HQY
Average EV/EBIT: 16.5
29.1
37%
0.8
US
UnitedHealth Group Inc
NYSE:UNH
12.9
-5%
N/A
US
A
Anthem Inc
LSE:0HG8
13.2
2%
6.6
US
Elevance Health Inc
NYSE:ELV
11.7
2%
5.8
US
Humana Inc
NYSE:HUM
11.2
8%
1.4
US
Centene Corp
NYSE:CNC
16.1
-22%
N/A
US
Molina Healthcare Inc
NYSE:MOH
2.8
-11%
N/A
US
M
Magellan Health Inc
F:MAH1
38.9
N/A N/A
US
Progyny Inc
NASDAQ:PGNY
23
51%
0.5
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -19.5 N/A N/A
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
5.7
24%
0.2

See Also

Summary
HQY intrinsic value, competitors valuation, and company profile.
DCF Valuation
HQY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HQY stock valuation using valuation multiples.
Wall Street Estimates
HQY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HQY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 304,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.